Japanese scientists from the Terasaki Institute have developed a method to produce living tissues using 3D printing based on egg white methacrylol (EWMA). The research was published in the scientific journal magazine Advanced Functional Materials (AFM).
Bioinks are used to create artificial tissues in 3D bioprinting. These natural or synthetic materials support living cells by promoting their adhesion, growth, and differentiation. These substances provide a nutrient-rich environment for cell growth while maintaining biocompatibility and bioactivity.
The team noted that their EWMA bioinks have properties such as flexibility that allow the material’s properties to be fine-tuned to meet the specific needs of multiple tissue constructs.
Bioengineers emphasized that the decisive advantage of methacryloyl bioinks could be their availability through the use of a common resource such as chicken eggs. Materials created using bioprinting are expected to be used to treat organ failure, cardiovascular diseases and cancer.
Earlier scientists It was announced about a breakthrough in bioprinting for organ transplantation.